載入...

COVID-19 and the nicotinic cholinergic system

The prevalence of smoking among hospitalised COVID-19 patients is low. COVID-19 manifestations could be linked to impairment of the cholinergic anti-inflammatory pathway. Nicotinic cholinergic agonists should be examined as potential therapeutic options. https://bit.ly/2zfUZ1S

Na minha lista:
書目詳細資料
發表在:Eur Respir J
Main Authors: Farsalinos, Konstantinos, Angelopoulou, Athina, Alexandris, Nikos, Poulas, Konstantinos
格式: Artigo
語言:Inglês
出版: European Respiratory Society 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7248130/
https://ncbi.nlm.nih.gov/pubmed/32444400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01589-2020
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!